Variant report

Variant	nsv579984
Chromosome Location	chr19:52133863-52157686
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:356)
CpG islands
(count:671)
Chromatin interactive
region (count:14)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:356 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:52140651-52140961	K562	blood:	n/a	n/a
2	ATF1	chr19:52154746-52155090	K562	blood:	n/a	n/a
3	ATF2	chr19:52154376-52154835	GM12878	blood:	n/a	n/a
4	BATF	chr19:52149947-52150214	GM12878	blood:	n/a	n/a
5	BCL11A	chr19:52149937-52150305	GM12878	blood:	n/a	n/a
6	BHLHE40	chr19:52147812-52147863	K562	blood:	n/a	n/a
7	BHLHE40	chr19:52150088-52150405	K562	blood:	n/a	chr19:52150169-52150178 chr19:52150169-52150178
8	BHLHE40	chr19:52150049-52150408	GM12878	blood:	n/a	chr19:52150169-52150178 chr19:52150169-52150178
9	BHLHE40	chr19:52133577-52133941	GM12878	blood:	n/a	chr19:52133745-52133754 chr19:52133745-52133754
10	BHLHE40	chr19:52154406-52154749	GM12878	blood:	n/a	n/a
11	CBX3	chr19:52140595-52141003	K562	blood:	n/a	n/a
12	CBX3	chr19:52140579-52140964	K562	blood:	n/a	n/a
13	CEBPB	chr19:52144942-52145259	A549	lung:	n/a	chr19:52145111-52145122
14	CEBPB	chr19:52145000-52145199	K562	blood:	n/a	chr19:52145111-52145122
15	CEBPB	chr19:52135506-52135630	K562	blood:	n/a	n/a
16	CEBPB	chr19:52135381-52135805	MCF-7	breast:	n/a	n/a
17	CEBPB	chr19:52144983-52145193	IMR90	lung:	n/a	chr19:52145111-52145122
18	CEBPB	chr19:52135414-52135743	MCF-7	breast:	n/a	n/a
19	CEBPB	chr19:52144962-52145257	HepG2	liver:	n/a	chr19:52145111-52145122
20	CTCF	chr19:52140713-52140931	GM12878	blood:	n/a	n/a
21	CTCF	chr19:52140442-52141373	A549	lung:	n/a	n/a
22	CTCF	chr19:52140740-52140890	SAEC	small airway:	n/a	n/a
23	CTCF	chr19:52140800-52140950	GM12878	blood:	n/a	n/a
24	CTCF	chr19:52140760-52140910	AG04450	lung:	n/a	n/a
25	CTCF	chr19:52140780-52140930	HUVEC	blood vessel:	n/a	n/a
26	CTCF	chr19:52140808-52140906	NHEK	skin:	n/a	n/a
27	CTCF	chr19:52140720-52140870	HUVEC	blood vessel:	n/a	n/a
28	CTCF	chr19:52141080-52141230	HPF	lung:	n/a	n/a
29	CTCF	chr19:52140780-52140930	BE2_C	brain:	n/a	n/a
30	CTCF	chr19:52140820-52140970	HEEpiC	esophagus:	n/a	n/a
31	CTCF	chr19:52141100-52141102	HUVEC	blood vessel:	n/a	n/a
32	CTCF	chr19:52140800-52140950	HA-sp	spinal cord:	n/a	n/a
33	CTCF	chr19:52140740-52140890	RPTEC	kidney:	n/a	n/a
34	CTCF	chr19:52140720-52140870	AG04449	skin:	n/a	n/a
35	CTCF	chr19:52140860-52141010	HAc	cerebellar:	n/a	n/a
36	CTCF	chr19:52140740-52140890	GM12870	blood:	n/a	n/a
37	CTCF	chr19:52140765-52140908	Spleen_OC	spleen:	n/a	n/a
38	CTCF	chr19:52140754-52140946	ProgFib	skin:	n/a	n/a
39	CTCF	chr19:52141020-52141170	K562	blood:	n/a	n/a
40	CTCF	chr19:52141080-52141230	A549	lung:	n/a	n/a
41	CTCF	chr19:52140780-52140930	AG09309	skin:	n/a	n/a
42	CTCF	chr19:52140740-52140890	GM12864	blood:	n/a	n/a
43	CTCF	chr19:52149993-52150038	GM19239	blood:	n/a	n/a
44	CTCF	chr19:52140810-52140933	GM19240	blood:	n/a	n/a
45	CTCF	chr19:52140780-52140930	HFF	foreskin:	n/a	n/a
46	CTCF	chr19:52140860-52140869	GM19239	blood:	n/a	n/a
47	CTCF	chr19:52140780-52140930	HRE	kidney:	n/a	n/a
48	CTCF	chr19:52140740-52140890	HRE	kidney:	n/a	n/a
49	CTCF	chr19:52140380-52140530	GM12872	blood:	n/a	n/a
50	CTCF	chr19:52141103-52141138	HUVEC	blood vessel:	n/a	n/a

(count:671 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:52146598-52146648	HNPCEpiC	eye:	n/a
2	chr19:52134296-52134346	HPAEpiC	pulmonary alveolar:	n/a
3	chr19:52150634-52150684	BJ	skin:	n/a
4	chr19:52146598-52146648	PFSK-1	brain:	n/a
5	chr19:52150230-52150280	SK-N-MC	brain:	n/a
6	chr19:52150230-52150280	BE2_C	brain:	n/a
7	chr19:52140097-52140147	Caco-2	colon:	n/a
8	chr19:52148354-52148404	SK-N-SH_RA	brain:	n/a
9	chr19:52150233-52150283	HAEpiC	amniotic membrane:	n/a
10	chr19:52150547-52150597	NT2-D1	testis:	n/a
11	chr19:52140097-52140147	GM12891	blood:	n/a
12	chr19:52140097-52140147	A549	lung:	n/a
13	chr19:52148354-52148404	GM19239	blood:	n/a
14	chr19:52140097-52140147	Hepatocyte	liver:	n/a
15	chr19:52148354-52148404	AG04450	lung:	fetal
16	chr19:52134289-52134339	HEK293	kidney:	embryo
17	chr19:52150230-52150280	HRE	kidney:	n/a
18	chr19:52148354-52148404	HCM	heart:	n/a
19	chr19:52133837-52133887	SAEC	small airway:	n/a
20	chr19:52150634-52150684	SK-N-SH	brain:	n/a
21	chr19:52140097-52140147	SK-N-SH_RA	brain:	n/a
22	chr19:52134393-52134443	HCT-116	colon:	n/a
23	chr19:52150230-52150280	AG10803	skin:	n/a
24	chr19:52133837-52133887	Hela-S3	cervix:	n/a
25	chr19:52134393-52134443	SKMC	muscle:	n/a
26	chr19:52134296-52134346	HRCEpiC	kidney:	n/a
27	chr19:52148354-52148404	U87	brain:	n/a
28	chr19:52150547-52150597	HEEpiC	esophagus:	n/a
29	chr19:52134296-52134346	Hela-S3	cervix:	n/a
30	chr19:52134393-52134443	HNPCEpiC	eye:	n/a
31	chr19:52150230-52150280	ovcar-3	ovarian:	n/a
32	chr19:52134296-52134346	GM19239	blood:	n/a
33	chr19:52134296-52134346	MCF-7	breast:	n/a
34	chr19:52134393-52134443	Hela-S3	cervix:	n/a
35	chr19:52148354-52148404	HEK293	kidney:	embryo
36	chr19:52140097-52140147	SK-N-MC	brain:	n/a
37	chr19:52150230-52150280	AoSMC	blood vessel:	n/a
38	chr19:52150233-52150283	NHDF-neo	bronchial:	n/a
39	chr19:52134296-52134346	AG09309	skin:	n/a
40	chr19:52134289-52134339	SK-N-SH_RA	brain:	n/a
41	chr19:52133837-52133887	GM12892	blood:	n/a
42	chr19:52150233-52150283	PrEC	prostate:	n/a
43	chr19:52148354-52148404	RPTEC	kidney:	n/a
44	chr19:52134393-52134443	NHDF-neo	bronchial:	n/a
45	chr19:52148354-52148404	NHDF-neo	bronchial:	n/a
46	chr19:52134393-52134443	ovcar-3	ovarian:	n/a
47	chr19:52134296-52134346	HCF	heart:	n/a
48	chr19:52134289-52134339	U87	brain:	n/a
49	chr19:52133837-52133887	NHDF-neo	bronchial:	n/a
50	chr19:52150547-52150597	PrEC	prostate:	n/a

(count:14 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:52140352..52141294-chr19:52160036..52160673,2	K562	blood:
2	chr19:52110923..52111673-chr19:52140530..52141292,3	MCF-7	breast:
3	chr19:52143293..52145764-chr19:52146395..52148250,2	K562	blood:
4	chr19:51965493..51967976-chr19:52153295..52156025,2	K562	blood:
5	chr19:52050848..52053096-chr19:52143769..52145532,2	K562	blood:
6	chr19:51978649..51980839-chr19:52139351..52142005,2	K562	blood:
7	chr19:52123766..52126647-chr19:52131236..52133976,2	K562	blood:
8	chr19:52110942..52111788-chr19:52140328..52140831,2	K562	blood:
9	chr19:51924865..51925857-chr19:52140333..52141234,3	K562	blood:
10	chr19:52143293..52145764-chr19:52146395..52148250,2	K562	blood:
11	chr19:51873847..51875580-chr19:52152831..52155624,2	K562	blood:
12	chr19:52017645..52019212-chr19:52145235..52147486,2	MCF-7	breast:
13	chr19:51960903..51963783-chr19:52139621..52141126,2	K562	blood:
14	chr19:51975813..51976889-chr19:52140105..52142089,6	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZNF175-5	chr19:52152115-52152863	NONHSAT067458
2	lnc-SIGLEC14-1	chr19:52148730-52148798	ENSG00000258669.1
3	lnc-SIGLEC14-1	chr19:52133552-52133919	ENSG00000258669.1

No data

Variant related genes	Relation type
SIGLEC14	TF binding region
ENSG00000268500	TF binding region
RPL7P51	TF binding region
SIGLEC5	TF binding region
SIGLEC14	CpG island
ENSG00000268500	CpG island
RPL7P51	CpG island
SIGLEC5	CpG island
ENSG00000105366	chromatin interactions
ENSG00000244071	chromatin interactions
ENSG00000213822	chromatin interactions

Extended variants
information (count: 876 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:876 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs8107979	chr19:52133863-52133864	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
2	rs186431035	chr19:52133905-52133906	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
3	rs539693765	chr19:52133908-52133909	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
4	rs76992492	chr19:52133927-52133928	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs570291283	chr19:52133947-52133948	Enhancers Flanking Active TSS Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs75983937	chr19:52133982-52133983	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs555315947	chr19:52134001-52134002	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs74176145	chr19:52134195-52134196	Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs190354362	chr19:52134256-52134257	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs146204540	chr19:52134271-52134272	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs145465138	chr19:52134334-52134335	Enhancers Active TSS Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs569509212	chr19:52134335-52134336	Enhancers Active TSS Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs11667857	chr19:52134345-52134346	Enhancers Active TSS Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs577908687	chr19:52134347-52134348	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs77612553	chr19:52134349-52134350	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs577831930	chr19:52134367-52134368	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs545263599	chr19:52134374-52134375	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs73562884	chr19:52134407-52134408	Enhancers Active TSS Weak transcription	CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs530785378	chr19:52134474-52134475	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs137883522	chr19:52134542-52134543	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs562078328	chr19:52134573-52134574	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs529280134	chr19:52134643-52134644	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs538115024	chr19:52134650-52134651	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs181680734	chr19:52134693-52134694	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs565878800	chr19:52134765-52134766	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs12974418	chr19:52134804-52134805	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs551906070	chr19:52134905-52134906	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs199703655	chr19:52134954-52134955	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs186649294	chr19:52135002-52135003	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs376459507	chr19:52135023-52135024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs61129759	chr19:52135025-52135026	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs142304106	chr19:52135035-52135036	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs146041734	chr19:52135069-52135070	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs190988739	chr19:52135102-52135103	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs61591050	chr19:52135178-52135179	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs58071912	chr19:52135185-52135186	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs554248631	chr19:52135250-52135251	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs534650772	chr19:52135251-52135252	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs139618745	chr19:52135254-52135255	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs10422815	chr19:52135282-52135283	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs545126724	chr19:52135288-52135289	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs149727113	chr19:52135293-52135294	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs575362579	chr19:52135320-52135321	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs10424577	chr19:52135371-52135372	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs561052717	chr19:52135388-52135389	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs527680888	chr19:52135497-52135498	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs540989484	chr19:52135542-52135543	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs559326414	chr19:52135609-52135610	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs116504461	chr19:52135656-52135657	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs551600106	chr19:52135659-52135660	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Adrenocortical carcinoma	18281524	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Cancer	20164920	CNVD
Melanoma	17363583	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:203 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:52131000-52134000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
2	chr19:52132600-52134600	Active TSS	Primary neutrophils fromperipheralblood	blood
3	chr19:52133600-52134000	Enhancers	Primary hematopoietic stem cells	blood
4	chr19:52133600-52134000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr19:52133600-52134200	Flanking Active TSS	Primary B cells from peripheral blood	blood
6	chr19:52133800-52134000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr19:52133800-52134000	Enhancers	Primary hematopoietic stem cells short term culture	blood
8	chr19:52133800-52134200	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
9	chr19:52133800-52134200	Flanking Active TSS	Primary B cells from cord blood	blood
10	chr19:52133800-52134200	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
11	chr19:52133800-52134200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
12	chr19:52133800-52134400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr19:52133800-52134600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr19:52133800-52135200	Enhancers	Placenta Amnion	Placenta Amnion
15	chr19:52133800-52136200	Enhancers	Placenta	Placenta
16	chr19:52134000-52134200	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
17	chr19:52134200-52134400	Enhancers	Primary B cells from cord blood	blood
18	chr19:52134200-52134600	Enhancers	Primary monocytes fromperipheralblood	blood
19	chr19:52134200-52134600	Enhancers	Primary B cells from peripheral blood	blood
20	chr19:52134200-52134600	Enhancers	Monocytes-CD14+_RO01746	blood
21	chr19:52134200-52140200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
22	chr19:52134200-52144400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
23	chr19:52134400-52138000	Weak transcription	Primary B cells from cord blood	blood
24	chr19:52134600-52137800	Weak transcription	Primary B cells from peripheral blood	blood
25	chr19:52134600-52139400	Weak transcription	Primary monocytes fromperipheralblood	blood
26	chr19:52134600-52139400	Weak transcription	Monocytes-CD14+_RO01746	blood
27	chr19:52135200-52140000	Weak transcription	Placenta Amnion	Placenta Amnion
28	chr19:52135400-52135600	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
29	chr19:52137800-52141200	Enhancers	Primary B cells from peripheral blood	blood
30	chr19:52138000-52140600	Enhancers	Primary B cells from cord blood	blood
31	chr19:52139400-52141200	Enhancers	Monocytes-CD14+_RO01746	blood
32	chr19:52139400-52141400	Enhancers	Primary monocytes fromperipheralblood	blood
33	chr19:52139600-52140800	Active TSS	Primary neutrophils fromperipheralblood	blood
34	chr19:52140000-52140200	Enhancers	Placenta Amnion	Placenta Amnion
35	chr19:52140200-52140600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
36	chr19:52141200-52142400	Weak transcription	Primary B cells from peripheral blood	blood
37	chr19:52141200-52142600	Weak transcription	Monocytes-CD14+_RO01746	blood
38	chr19:52141400-52142200	Weak transcription	Primary monocytes fromperipheralblood	blood
39	chr19:52142200-52143600	Strong transcription	Primary monocytes fromperipheralblood	blood
40	chr19:52142400-52143600	Strong transcription	Primary B cells from peripheral blood	blood
41	chr19:52142600-52144000	Strong transcription	Monocytes-CD14+_RO01746	blood
42	chr19:52143600-52147800	Genic enhancers	Primary monocytes fromperipheralblood	blood
43	chr19:52143600-52147800	Genic enhancers	Primary B cells from peripheral blood	blood
44	chr19:52144000-52144200	Weak transcription	Monocytes-CD14+_RO01746	blood
45	chr19:52144200-52145400	Enhancers	Monocytes-CD14+_RO01746	blood
46	chr19:52144400-52144600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
47	chr19:52144600-52146400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
48	chr19:52144600-52146800	Weak transcription	Spleen	Spleen
49	chr19:52145400-52145600	Genic enhancers	Monocytes-CD14+_RO01746	blood
50	chr19:52145400-52148000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links